Imunon (IMNN) Gains from Investment Securities (2013 - 2015)
Imunon's (IMNN) quarterly Gains from Investment Securities came in at $18018.0 in Q2 2015, down 3.2% YoY from $18613.0 in Q2 2014, and down 58.32% on a QoQ basis from $43228.0 in Q1 2015.
Imunon (IMNN) Gains from Investment Securities (2013 - 2015) Analysis & Trends
Imunon (IMNN) has 3 years of Gains from Investment Securities data on file, last reported at $18018.0 in Q2 2015.
- Quarterly Gains from Investment Securities fell 3.2% year-over-year to $18018.0 in Q2 2015, while the trailing twelve-month figure through Dec 2015 was $61246.0 (up 129.98% YoY) and the FY2015 annual result came in at $61246.0, up 129.98% from the prior year.
- Gains from Investment Securities retreated to $18018.0 in Q2 2015, from $43228.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $50938.0 in Q4 2013 to a low of -$123036.0 in Q4 2014.
- A 3-year average of -$13156.4 and a median of $18018.0 in 2015 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2014 — Gains from Investment Securities slumped 341.54% — and 2015, when it surged 1528.55%.
- Tracing IMNN's Gains from Investment Securities over 3 years: stood at $50938.0 in 2013, then sank by 341.54% to -$123036.0 in 2014, then surged by 114.64% to $18018.0 in 2015.
- The last three Gains from Investment Securities figures came in at $18018.0 (Q2 2015), $43228.0 (Q1 2015), and -$123036.0 (Q4 2014), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 18,018.00 |
| Jun 30, 2015 | 18,018.00 |
| Mar 31, 2015 | 43,228.00 |
| Mar 31, 2015 | 43,228.00 |
| Dec 31, 2014 | -123,036.00 |
| Dec 31, 2014 | -123,036.00 |
| Sep 30, 2014 | -96,830.00 |
| Sep 30, 2014 | -96,830.00 |
| Jun 30, 2014 | 18,613.00 |
| Jun 30, 2014 | 18,613.00 |
| Mar 31, 2014 | -3,026.00 |
| Mar 31, 2014 | -3,026.00 |
| Dec 31, 2013 | 50,938.00 |
| Dec 31, 2013 | 50,938.00 |